A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/1999
12/02/1999	WO1999061437A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999	WO1999061430A1 Benzofuroxan derivatives and their use in treating angina pectoris
12/02/1999	WO1999061427A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999	WO1999061426A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999	WO1999061424A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
12/02/1999	WO1999061423A1 New heterocyclically substituted amides, their production and their use
12/02/1999	WO1999061422A1 Pyrrole substituted 2-indolinone protein kinase inhibitors
12/02/1999	WO1999061421A1 A NOVEL VLA-4 INHIBITOR: oMePUPA-V
12/02/1999	WO1999061097A2 Alpha emitting constructs and uses thereof
12/02/1999	WO1999061035A1 Preparation based on the artichoke plant, especially for use as a medicament or food supplement
12/02/1999	WO1999061030A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZOÏC ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-λB
12/02/1999	WO1999061018A1 Use of benzofuroxan derivatives in treating angina pectoris
12/02/1999	WO1999060984A2 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/02/1999	WO1999053942A8 Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases
12/02/1999	WO1999050413A3 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
12/02/1999	CA2333537A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999	CA2333157A1 Novel substituted imidazole compounds
12/02/1999	CA2333040A1 Imidazopyridine thrombin inhibitors
12/02/1999	CA2333001A1 Benzofuroxan derivatives and their use in treating angina pectoris
12/02/1999	CA2332950A1 Use of benzofuroxan derivatives in treating angina pectoris
12/02/1999	CA2332863A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor nf-.kappa.b
12/02/1999	CA2332459A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999	CA2332402A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999	CA2329274A1 Interleukin-21
12/02/1999	CA2329072A1 Human transmembrane proteins
12/02/1999	CA2327541A1 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/01/1999	EP0960883A1 Substituted thiazolidinedione derivatives
12/01/1999	EP0960882A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/01/1999	EP0960334A1 Vegf-b/receptor complex and uses thereof
12/01/1999	EP0960211A1 Compositions and methods for the identification and treatment of patients at risk for heart failure
12/01/1999	EP0960141A1 Cross-linked vinyl polymers with bile acid adsorbing effect
12/01/1999	EP0959903A1 NOVEL FabD
12/01/1999	EP0959887A1 Pharmaceutically active compounds and methods of use
12/01/1999	EP0959886A1 Triaryl substituted imidazoles as glucagon antagonists
12/01/1999	EP0959885A1 Triaryl substituted imidazoles and methods of use
12/01/1999	EP0959781A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins
12/01/1999	EP0850235B1 Quinolein-2(1h)-one derivatives as serotonin antagonists
12/01/1999	EP0800504B1 Tricyclic retinoids, methods for their production and use
12/01/1999	EP0788491B1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives
12/01/1999	EP0655056B1 Azacyclyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
12/01/1999	CN1237179A 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivatives
12/01/1999	CN1237168A Bicyclic aryl carboxamides and their therapeutic use
12/01/1999	CN1236780A Pyrazolopyrimidines and pyrazolotriazines
12/01/1999	CN1046942C Imidazopyridines
11/1999
11/30/1999	US5994539 Mercapto acyl aminoacid derivatives endowed with dual ACE-NEP inhibitory activity, useful in the treatment of cardiovascular diseases
11/30/1999	US5994537 Process for preparing azepinone compounds useful in the inhibition of ACE and NEP
11/30/1999	US5994513 Oncoprotein protein kinase
11/30/1999	US5994391 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
11/30/1999	US5994384 Hypersensitization of adrenergic receptors
11/30/1999	US5994371 Carbamate derivatives of 3-aroylbenzo[b] thiophenes
11/30/1999	US5994369 Substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
11/30/1999	US5994354 Cyclic urethanes useful as antiarrhythmic and antifibrillatory agents
11/30/1999	US5994350 Cardiovascular disorders; central nervous system disorders; gastrointestinal disorders; respiratory system disorders
11/30/1999	US5994344 Bronchitis therapy
11/30/1999	US5994332 Antiinflammatory agents; immunomodulators; skin disorders
11/30/1999	US5994312 Peptidyl compounds
11/30/1999	US5994311 Using a oligopeptides, polypeptide
11/30/1999	US5994303 Use of insulin and IGF-I
11/30/1999	US5994300 Vascular endothelial cell growth factor C subunit
11/30/1999	US5994293 Peptidyl compounds and their therapeutic use
11/30/1999	US5994125 A synthetic oligonucleotide; anticoagulant, hypertensive agent, antiinflammatory agent,
11/30/1999	US5994112 A polynucleotide which codes a protein; antiproliferative agents, anticarcinogenic agents, antiinflammatory agents
11/30/1999	US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999	US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999	US5994096 Regulator
11/30/1999	US5993859 Pharmaceutical agents
11/30/1999	US5993855 Microspheres prepared by emulsifying an aqueous phase containing a drug and an oil phase containing a biodegradable polylactide to form a w/o emulsion, and then mixing and agitating this emulsion with another aqueous phase to form a
11/30/1999	US5993779 Interrupting an aorta at least at two sites, forming an isolated segment including branched parts of radicular arteries, feeding the spinal cord between the sites of interruption, bringing to ischemia, administering glu or asp
11/30/1999	CA2098495C 1,4-benzothiazepine derivatives
11/30/1999	CA2019035C Stabilized radiopharmaceutical compositions
11/30/1999	CA1340836C Mixed compositions for treating hypercholesterolemia
11/25/1999	WO1999060171A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999	WO1999060125A2 Secreted proteins
11/25/1999	WO1999060015A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999	WO1999060013A2 Il-6 antagonist peptides
11/25/1999	WO1999059992A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
11/25/1999	WO1999059987A1 5-demethoxyfumagillol derivatives and processes for preparing the same
11/25/1999	WO1999059986A1 Fumagillol derivatives and processes for preparing the same
11/25/1999	WO1999059975A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999	WO1999059973A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999	WO1999059969A1 Compositions comprising 2-phenyl-indole compounds and estrogen formulations
11/25/1999	WO1999059966A1 METHOD OF LOCKING 1α-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION
11/25/1999	WO1999059964A1 Novel analogs of 16-hydroxyeicosatetraenoic acid
11/25/1999	WO1999059959A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/25/1999	WO1999059957A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
11/25/1999	WO1999059811A1 Multi-action particle for structuring biological media
11/25/1999	WO1999059620A1 Angiostatin receptor
11/25/1999	WO1999059606A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
11/25/1999	WO1999059594A1 Potassium channel agonists
11/25/1999	WO1999059581A1 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
11/25/1999	WO1999059557A1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method
11/25/1999	WO1999059553A1 Effervescent preparations
11/25/1999	WO1999059549A1 Biodegradable sustained-release alginate gels
11/25/1999	WO1999059499A2 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders
11/25/1999	WO1999050249A3 Pyrimidines and triazines as integrin antagonists
11/25/1999	WO1999048507A3 Steroidal saponins for treating alzheimer's disease
11/25/1999	WO1999047545A3 Inhibitors of caspases
11/25/1999	WO1999047158A3 Therapeutic chemokine receptor antagonists
11/25/1999	DE19819012A1 Feuersichere, nicht explosionsfähige, Nitroglycerin und wasserfreie Lactose enthaltende Feststoffmischungen Fire-proof, non-explosive, containing nitroglycerin and anhydrous lactose mixtures of solids
11/25/1999	CA2690399A1 Il-6 antagonist peptides

1 ... 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 ... 1595